The combination therapy of cilostazol and ischemic postconditioning protects against ischemia-reperfusion injury in non-diabetic and diabetic rat hearts with long-term atorvastatin treatment
The combination therapy of cilostazol and ischemic postconditioning protects against ischemia-reperfusion injury in non-diabetic and diabetic rat hearts with long-term atorvastatin treatment